Discover how scientists are targeting CD25 on leukemic stem cells to develop new treatments for Chronic Myeloid Leukemia (CML).
Breakthrough discovery of CD25 as a STAT5-controlled lifeline for leukemic stem cells in chronic myeloid leukemia (CML) and its therapeutic implications.